Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Current and Projected Market Size of the Pharmaceutical Manufacturing Market Through 2034?
The market size of pharmaceutical manufacturing has seen a swift expansion in the past few years. It is projected to rise from $519.78 billion in 2024 to $572.33 billion in 2025, with a compound annual growth rate (CAGR) of 10.1%. Factors such as the worldwide escalation of diseases, growth in healthcare expenditure, mounting demand for generic drugs, expiry of patents for blockbuster drugs, and enlargement of pharmaceutical production capabilities account for the historical growth.
The market size of pharmaceutical manufacturing is projected to experience swift expansion in the coming years, increasing to$841.14 billion in 2029 with a compound annual growth rate (CAGR) of 10.1%. Factors contributing to this growth during the projected period include developments in personalized medicine, an increasing elderly populace, a rising demand for biosimilars, government backing for domestic manufacturing, and an escalating prevalence of chronic illnesses. Emerging trends in the forecast period encompass improvements in uninterrupted manufacturing, the integration of artificial intelligence, the adoption of intelligent manufacturing technologies, breakthroughs in biologics production, and an emphasis on research and development efficacy.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24375&type=smp
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of thePharmaceutical Manufacturing Market?
The escalation in chronic illnesses prevalence is predicted to propel the expansion of the pharmaceutical manufacturing market. Chronic illnesses are enduring health issues that generally develop gradually over a year or more, often necessitating continued medical supervision or constraining daily activities. The surge in chronic illnesses correlates with heightened life expectancy, inactive lifestyles, and unhealthy eating habits. This contributes to an elevated demand for long-term healthcare solutions and preventive wellness strategies. Pharmaceutical manufacturing plays a pivotal role in combating chronic diseases by ensuring a consistent supply of crucial medications, fostering drug development innovation, and fulfilling the escalating requirement for potent long-term treatment options. For example, the National Health Service, a UK government agency, reported in September 2024 that 11% of adults aged 35 and above suffer from advanced chronic kidney disease. The prevalence and severity of the disease increase with age, with nearly 48% of individuals aged 75 and above affected by some form of the disease, and 36% facing more serious stages. Consequently, the rising prevalence of chronic diseases is stimulating growth in the pharmaceutical manufacturing market.
Which Segments in the Pharmaceutical Manufacturing Offer the Most Growth?
The pharmaceutical manufacturingmarket covered in this report is segmented –
1) By Molecule Type: Biologics And Biosimilars; Conventional Drugs
2) By Formulation: Tablets; Capsules; Injectable; Sprays; Suspensions; Powders; Other Formulations
3) By Route Of Administration: Oral; Topical; Parenteral; Inhalations; Other Route Of Administrations
4) By Therapy Area: Cardiovascular Diseases (CVDs); Pain; Diabetes; Cancer; Respiratory Diseases; Other Diseases
5) By Sales Channel: Retail; Non-retail
Subsegments:
1) By Biologics And Biosimilars: Monoclonal Antibodies; Vaccines; Recombinant Proteins; Cell Therapies; Gene Therapies; Hormones; Blood And Plasma Products
2) By Conventional Drugs: Analgesics; Antipyretics; Antibiotics; Antivirals; Antifungals; Antihypertensives; Antidepressants; Antidiabetics
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=24375&type=smp
What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of thePharmaceutical Manufacturing Market?# Market?
North America was the largest region in the pharmaceutical manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Current Market Growth and Trends in the Pharmaceutical Manufacturing Industry?
The key players in the pharmaceutical manufacturing industry are prioritizing the development of innovative systems, such as fully mechanized Radioligand Therapy (RLT) production plants, with the intention to optimize production effectiveness, guarantee superior quality standards, and address the escalating demand for specialized cancer treatments. A modernized RLT production plant represents a progressive production location that employs leading-edge automation technologies to refine and enhance the creation of radioligand therapies, guaranteeing steady, proficient, and expandable production. Importantly, in January 2024, Novartis AG, an eminent pharmaceutical firm based in Switzerland, obtained authorization from the US Food and Drug Administration (FDA) for producing Pluvicto at an advanced RLT production facility in Indianapolis, which is projected to considerably boost the production quantity of its radioligand therapy medications, including Pluvicto and Lutathera. This growth forms an integral part of Novartis’ comprehensive plan to cater to the rising international demand for specialized cancer treatments and amplify accessibility for patients globally.
View the full report here:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-manufacturing-global-market-report
What Are the Key Elements That Define the Pharmaceutical Manufacturing Market?
Pharmaceutical manufacturing is the industrial process of developing, producing, and packaging medications and medical products at scale through chemical synthesis, biological processing, and formulation of active and inactive ingredients, carried out under stringent regulatory and quality control standards to ensure the safety, efficacy, consistency, and compliance of drugs intended for human and veterinary use across global healthcare systems.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24375
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model